• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NAD 生物合成和消耗酶作为先天和适应性免疫反应在癌症代谢调控中的核心参与者。

NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer.

机构信息

Department of Medical Sciences, University of Turin, Turin, Italy.

Italian Institute for Genomic Medicine, Turin, Italy.

出版信息

Front Immunol. 2019 Jul 25;10:1720. doi: 10.3389/fimmu.2019.01720. eCollection 2019.

DOI:10.3389/fimmu.2019.01720
PMID:31402913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6671870/
Abstract

Cancer cells, particularly in solid tumors, are surrounded by non-neoplastic elements, including endothelial and stromal cells, as well as cells of immune origin, which can support tumor growth by providing the right conditions. On the other hand, local hypoxia, and lack of nutrients induce tumor cells to reprogram their metabolism in order to survive, proliferate, and disseminate: the same conditions are also responsible for building a tumor-suppressive microenvironment. In addition to tumor cells, it is now well-recognized that metabolic rewiring occurs in all cellular components of the tumor microenvironment, affecting epigenetic regulation of gene expression and influencing differentiation/proliferation decisions of these cells. Nicotinamide adenine dinucleotide (NAD) is an essential co-factor for energy transduction in metabolic processes. It is also a key component of signaling pathways, through the regulation of NAD-consuming enzymes, including sirtuins and PARPs, which can affect DNA plasticity and accessibility. In addition, both NAD-biosynthetic and NAD-consuming enzymes can be present in the extracellular environment, adding a new layer of complexity to the system. In this review we will discuss the role of the "NADome" in the metabolic cross-talk between cancer and infiltrating immune cells, contributing to cancer growth and immune evasion, with an eye to therapeutic implications.

摘要

癌细胞,特别是在实体肿瘤中,被非肿瘤性细胞所包围,包括内皮细胞和基质细胞,以及免疫来源的细胞,这些细胞可以通过提供适当的条件来支持肿瘤生长。另一方面,局部缺氧和缺乏营养会诱导肿瘤细胞重新编程其代谢,以存活、增殖和扩散:同样的条件也负责构建肿瘤抑制性微环境。除了肿瘤细胞,现在人们已经认识到,代谢重编程发生在肿瘤微环境的所有细胞成分中,影响基因表达的表观遗传调控,并影响这些细胞的分化/增殖决策。烟酰胺腺嘌呤二核苷酸(NAD)是代谢过程中能量转导的必需辅酶。它也是信号通路的关键组成部分,通过调节 NAD 消耗酶,包括沉默调节蛋白和 PARP,可以影响 DNA 的可塑性和可及性。此外,NAD 合成酶和 NAD 消耗酶都可以存在于细胞外环境中,为系统增加了一层新的复杂性。在这篇综述中,我们将讨论“NADome”在癌症和浸润性免疫细胞之间代谢交叉对话中的作用,它有助于癌症的生长和免疫逃避,并着眼于治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/ec2865635d08/fimmu-10-01720-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/02369f104eb1/fimmu-10-01720-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/38b0b3838ea1/fimmu-10-01720-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/00caf5b437ce/fimmu-10-01720-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/279fb5e05221/fimmu-10-01720-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/0c36cdb54216/fimmu-10-01720-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/ec2865635d08/fimmu-10-01720-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/02369f104eb1/fimmu-10-01720-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/38b0b3838ea1/fimmu-10-01720-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/00caf5b437ce/fimmu-10-01720-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/279fb5e05221/fimmu-10-01720-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/0c36cdb54216/fimmu-10-01720-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2578/6671870/ec2865635d08/fimmu-10-01720-g0006.jpg

相似文献

1
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer.NAD 生物合成和消耗酶作为先天和适应性免疫反应在癌症代谢调控中的核心参与者。
Front Immunol. 2019 Jul 25;10:1720. doi: 10.3389/fimmu.2019.01720. eCollection 2019.
2
Tissue-specific regulation of sirtuin and nicotinamide adenine dinucleotide biosynthetic pathways identified in C57Bl/6 mice in response to high-fat feeding.高脂喂养 C57Bl/6 小鼠中组织特异性调节的烟酰胺腺嘌呤二核苷酸生物合成途径及其与沉默调节蛋白的关系。
J Nutr Biochem. 2016 Nov;37:20-29. doi: 10.1016/j.jnutbio.2016.07.013. Epub 2016 Aug 14.
3
The cancer metabolic reprogramming and immune response.癌症代谢重编程与免疫应答。
Mol Cancer. 2021 Feb 5;20(1):28. doi: 10.1186/s12943-021-01316-8.
4
Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing.烟酰胺腺嘌呤二核苷酸在免疫反应、自身免疫和炎症衰老中的代谢
Br J Pharmacol. 2022 May;179(9):1839-1856. doi: 10.1111/bph.15477. Epub 2021 May 12.
5
Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.调节性 T 细胞动力学的免疫代谢检查点:适应微环境的机遇与挑战。
Front Immunol. 2019 Aug 27;10:1889. doi: 10.3389/fimmu.2019.01889. eCollection 2019.
6
Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications.肿瘤微环境中的代谢物通过表观遗传修饰重新编程免疫效应细胞的功能。
Front Immunol. 2021 Apr 13;12:641883. doi: 10.3389/fimmu.2021.641883. eCollection 2021.
7
The Extracellular NADome Modulates Immune Responses.细胞外 NAD 动态变化调控免疫应答。
Front Immunol. 2021 Aug 4;12:704779. doi: 10.3389/fimmu.2021.704779. eCollection 2021.
8
Sirtuins and the Metabolic Hurdles in Cancer.沉默调节蛋白与癌症中的代谢障碍
Curr Biol. 2015 Jun 29;25(13):R569-83. doi: 10.1016/j.cub.2015.05.012.
9
TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.TLR 介导的肿瘤微环境代谢重编程:癌症免疫治疗的潜在新策略。
Cell Mol Immunol. 2018 May;15(5):428-437. doi: 10.1038/cmi.2018.4. Epub 2018 Mar 19.
10
Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders.NAD⁺代谢在线粒体及年龄相关疾病中的新兴治疗作用
Clin Transl Med. 2016 Dec;5(1):25. doi: 10.1186/s40169-016-0104-7. Epub 2016 Jul 27.

引用本文的文献

1
Prognostic Value of Systemic Inflammatory Response Markers for CIN2+ Recurrence After Loop Electrosurgical Excision Procedure: A Retrospective Cohort Study.环行电刀切除术治疗CIN2+后全身炎症反应标志物对复发的预后价值:一项回顾性队列研究
J Clin Med. 2025 Jun 8;14(12):4059. doi: 10.3390/jcm14124059.
2
Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease.二肽基肽酶 1 抑制作为中性粒细胞介导致炎疾病的一种潜在治疗方法。
Front Immunol. 2023 Dec 14;14:1239151. doi: 10.3389/fimmu.2023.1239151. eCollection 2023.
3
Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer.

本文引用的文献

1
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT).针对转移性黑色素瘤的代谢重编程:烟酰胺磷酸核糖转移酶(NAMPT)的关键作用。
Semin Cell Dev Biol. 2020 Feb;98:192-201. doi: 10.1016/j.semcdb.2019.05.001. Epub 2019 May 14.
2
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation.髓系来源抑制细胞:肿瘤转移前生态位形成的关键罪犯。
Front Immunol. 2019 Feb 7;10:172. doi: 10.3389/fimmu.2019.00172. eCollection 2019.
3
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells.
对一种源自NAD+代谢的基因特征进行综合分析,以预测子宫内膜癌的预后和免疫格局。
Biomol Biomed. 2024 Mar 11;24(2):346-359. doi: 10.17305/bb.2023.9489.
4
The immunomodulatory role of IDO1-Kynurenine-NAD pathway in switching cold tumor microenvironment in PDAC.吲哚胺 2,3-双加氧酶 1-犬尿氨酸-NAD 途径在胰腺癌冷肿瘤微环境转变中的免疫调节作用
Front Oncol. 2023 Jun 30;13:1142838. doi: 10.3389/fonc.2023.1142838. eCollection 2023.
5
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma.肿瘤微环境介导的肝细胞癌免疫逃逸。
Front Immunol. 2023 Feb 10;14:1133308. doi: 10.3389/fimmu.2023.1133308. eCollection 2023.
6
PPARs and the Kynurenine Pathway in Melanoma-Potential Biological Interactions.过氧化物酶体增殖物激活受体与黑色素瘤中的犬尿氨酸途径:潜在的生物学相互作用。
Int J Mol Sci. 2023 Feb 4;24(4):3114. doi: 10.3390/ijms24043114.
7
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease.烟酰胺磷酸核糖转移酶(NAMPT)和烟酰胺磷酸核糖基转移酶(NAPRT)血清水平可预测炎症性肠病患者对抗肿瘤坏死因子(TNF)治疗的反应。
Front Med (Lausanne). 2023 Feb 1;10:1116862. doi: 10.3389/fmed.2023.1116862. eCollection 2023.
8
Prognostic value of nicotinamide adenine dinucleotide (NAD) metabolic genes in patients with stomach adenocarcinoma based on bioinformatics analysis.基于生物信息学分析的烟酰胺腺嘌呤二核苷酸(NAD)代谢基因在胃腺癌患者中的预后价值
J Gastrointest Oncol. 2022 Dec;13(6):2845-2862. doi: 10.21037/jgo-22-1092.
9
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma.肝细胞癌患者对免疫检查点抑制剂原发性和获得性耐药的机制
Cancers (Basel). 2022 Sep 23;14(19):4616. doi: 10.3390/cancers14194616.
10
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets.NAD/NAMPT 和 mTOR 通路在黑色素瘤中的作用:耐药性的驱动因素和潜在的治疗靶点。
Int J Mol Sci. 2022 Sep 1;23(17):9985. doi: 10.3390/ijms23179985.
烟酰胺磷酸核糖转移酶作为动员髓源性抑制细胞的代谢门控。
Cancer Res. 2019 Apr 15;79(8):1938-1951. doi: 10.1158/0008-5472.CAN-18-1544. Epub 2019 Feb 18.
4
Immunotherapy in myeloma: how far have we come?骨髓瘤的免疫疗法:我们已经取得了多大进展?
Ther Adv Hematol. 2019 Jan 18;10:2040620718822660. doi: 10.1177/2040620718822660. eCollection 2019.
5
Metabolism Plays a Key Role during Macrophage Activation.代谢在巨噬细胞激活中起着关键作用。
Mediators Inflamm. 2018 Dec 10;2018:2426138. doi: 10.1155/2018/2426138. eCollection 2018.
6
Sirtuin-1 in immunotherapy: A Janus-headed target.Sirtuin-1 在免疫疗法中的作用:一把双刃剑。
J Leukoc Biol. 2019 Aug;106(2):337-343. doi: 10.1002/JLB.2RU1118-422R. Epub 2019 Jan 3.
7
Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity.组织驻留 CD8 记忆 T 细胞在癌症和自身免疫中的反应。
Front Immunol. 2018 Nov 29;9:2810. doi: 10.3389/fimmu.2018.02810. eCollection 2018.
8
Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives.髓源性抑制细胞与肿瘤:当前的认识与未来展望。
J Cell Physiol. 2019 Jul;234(7):9966-9981. doi: 10.1002/jcp.27923. Epub 2018 Dec 7.
9
Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.靶向 Sirt-1 通过抑制 T 细胞同种反应和促进 Treg 稳定性来控制 GVHD。
Blood. 2019 Jan 17;133(3):266-279. doi: 10.1182/blood-2018-07-863233. Epub 2018 Dec 4.
10
Turning foes to friends: targeting cancer-associated fibroblasts.化敌为友:靶向肿瘤相关成纤维细胞。
Nat Rev Drug Discov. 2019 Feb;18(2):99-115. doi: 10.1038/s41573-018-0004-1.